0001209191-23-054273.txt : 20231102
0001209191-23-054273.hdr.sgml : 20231102
20231102213659
ACCESSION NUMBER: 0001209191-23-054273
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20231102
FILED AS OF DATE: 20231102
DATE AS OF CHANGE: 20231102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENRIGHT PATRICK G
CENTRAL INDEX KEY: 0001253886
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231374320
MAIL ADDRESS:
STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tammenoms Bakker Juliet
CENTRAL INDEX KEY: 0001431159
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231374321
MAIL ADDRESS:
STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Venture Partners IV, L.P.
CENTRAL INDEX KEY: 0001787456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231374322
BUSINESS ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: (650) 854-5700
MAIL ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Capital Partners IV, LLC
CENTRAL INDEX KEY: 0001829169
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41855
FILM NUMBER: 231374323
BUSINESS ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-854-5700
MAIL ADDRESS:
STREET 1: 2740 SAND HILL ROAD
STREET 2: 2ND FLOOR
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexeo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001907108
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: FLOOR 14
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: (212) 547-9879
MAIL ADDRESS:
STREET 1: 430 E. 29TH STREET
STREET 2: FLOOR 14
CITY: NEW YORK
STATE: NY
ZIP: 10016
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-11-02
0
0001907108
Lexeo Therapeutics, Inc.
LXEO
0001829169
Longitude Capital Partners IV, LLC
2740 SAND HILL ROAD
2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001787456
Longitude Venture Partners IV, L.P.
2740 SAND HILL ROAD
2ND FLOOR
MENLO PARK
CA
0
0
1
0
0001431159
Tammenoms Bakker Juliet
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001253886
ENRIGHT PATRICK G
C/O LONGITUDE CAPITAL
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
Series A convertible preferred stock
Common Stock
1793429
I
By Longitude Venture Partners IV, L.P.
Series B convertible preferred stock
Common Stock
274314
I
By Longitude Venture Partners IV, L.P.
Each share of Series A convertible preferred stock is convertible into Common Stock on a 1-for-10.594230 basis at any time at the Reporting Person's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.
These shares are held by Longitude Venture Partners IV, L.P ("LVP IV"). Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of LVP IV and may be deemed to have voting and dispositive power over the shares held by LVP IV. Mr. Enright and Ms. Tammenoms Bakker are managing members of LCP IV and may be deemed to share voting and dispositive power with respect to the shares held by LVP IV. Each of LCP IV, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Each share of Series B convertible preferred stock is convertible into Common Stock on a 1-for-10.594230 basis at any time at the Reporting Person's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. Excludes shares of Common Stock issuable upon the closing of the Issuer's initial public offering pursuant to anti-dilution adjustment provisions of the Series B convertible preferred stock. The shares have no expiration date.
Longitude Capital Partners IV, LLC By: /s/ Cristiana Blauth Oliveira , Authorized Signatory
2023-11-02
Longitude Venture Partners IV, L.P. By: /s/ Cristiana Blauth Oliveira , Authorized Signatory of the General Partner
2023-11-02
/s/ Cristiana Blauth Oliveira , Attorney-in-Fact for Juliet Tammenoms Bakker
2023-11-02
/s/ Cristiana Blauth Oliveira, Attorney-in-Fact for Patrick Enright
2023-11-02
EX-24
2
poa.txt
POA DOCUMENT
EXHBIT 24
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints
Cristiana Blauth Oliveira as the undersigned's true and lawful attorney-in-fact
(the "Attorney-in-Fact") to:
1. execute for and on behalf of the undersigned (the "Reporting Person") a Form
ID Application and/or "Update Passphrase Confirmation," if required, and submit
the same to the United States Securities and Exchange Commission (the
"Commission");
2. execute for and on behalf of the Reporting Person any and all reports,
notices, communications and other documents (including, but not limited to,
reports on Schedule 13D, Schedule 13G, Form 13-F, Form 3, Form 4 and Form 5)
that such Reporting Person may be required to file with the Commission pursuant
to the Securities Act of 1933, as amended, and the Securities Exchange Act of
1934, as amended (collectively, the "Reports") with respect to the Reporting
Person's (a) status as an officer or director of, or (b) ownership of, or
transactions in, securities of, any entity whose securities are beneficially
owned (directly or indirectly) by such Reporting Person (each, a "Company");
3. do and perform any and all acts for and on behalf of the Reporting Person
which may be necessary or desirable to complete and execute any such Reports and
timely file such forms and schedules with the Commission and any stock exchange
or similar authority; and
4. take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of the Attorney-in-Fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood that
the documents executed by the Attorney-in-Fact on behalf of the undersigned,
pursuant to this Power of Attorney, shall be in such form and shall contain such
terms and conditions as the Attorney-in-Fact may approve in the
Attorney-in-Fact's discretion.
The undersigned hereby grants to the Attorney-in-Fact full power and authority
to do and perform all and every act and thing whatsoever requisite, necessary,
and proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that the Attorney-in-Fact, or her substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5, Form 13F or
Schedules 13G/D with respect to the undersigned's holdings of and transactions
in securities issued by the Company, unless earlier revoked by the undersigned
in a signed writing delivered to the Attorney-in-Fact. The Reporting Person
acknowledges that the Attorney-in-Fact, in serving in such capacity at the
request of the undersigned, is not hereby assuming any of the undersigned's
responsibilities to comply with Section 13 or Section 16 of the Securities
Exchange Act of 1934 and state or federal securities laws. This Power of
Attorney may be filed with the Commission as a confirming statement of the
authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this March 15, 2023.
/s/ Juliet Tammenoms Bakker
Juliet Tammenoms Bakker
EXBIBIT 24.1
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints
Cristiana Blauth Oliveira as the undersigned's true and lawful attorney-in-fact
(the "Attorney-in-Fact") to:
1. execute for and on behalf of the undersigned (the "Reporting Person") a Form
ID Application and/or "Update Passphrase Confirmation," if required, and submit
the same to the United States Securities and Exchange Commission (the
"Commission");
2. execute for and on behalf of the Reporting Person any and all reports,
notices, communications and other documents (including, but not limited to,
reports on Schedule 13D, Schedule 13G, Form 13-F, Form 3, Form 4 and Form 5)
that such Reporting Person may be required to file with the Commission pursuant
to the Securities Act of 1933, as amended, and the Securities Exchange Act of
1934, as amended (collectively, the "Reports") with respect to the Reporting
Person's (a) status as an officer or director of, or (b) ownership of, or
transactions in, securities of, any entity whose securities are beneficially
owned (directly or indirectly) by such Reporting Person (each, a "Company");
3. do and perform any and all acts for and on behalf of the Reporting Person
which may be necessary or desirable to complete and execute any such Reports and
timely file such forms and schedules with the Commission and any stock exchange
or similar authority; and
4. take any other action of any type whatsoever in connection with the foregoing
which, in the opinion of the Attorney-in-Fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it being understood that
the documents executed by the Attorney-in-Fact on behalf of the undersigned,
pursuant to this Power of Attorney, shall be in such form and shall contain such
terms and conditions as the Attorney-in-Fact may approve in the
Attorney-in-Fact's discretion.
The undersigned hereby grants to the Attorney-in-Fact full power and authority
to do and perform all and every act and thing whatsoever requisite, necessary,
and proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that the Attorney-in-Fact, or her substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5, Form 13F or
Schedules 13G/D with respect to the undersigned's holdings of and transactions
in securities issued by the Company, unless earlier revoked by the undersigned
in a signed writing delivered to the Attorney-in-Fact. The Reporting Person
acknowledges that the Attorney-in-Fact, in serving in such capacity at the
request of the undersigned, is not hereby assuming any of the undersigned's
responsibilities to comply with Section 13 or Section 16 of the Securities
Exchange Act of 1934 and state or federal securities laws. This Power of
Attorney may be filed with the Commission as a confirming statement of the
authority granted herein.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this March 15, 2023.
/s/ Patrick G. Enright
Patrick G. Enright